Insmed has launched a first-in-human Phase 1 trial testing its experimental ALS gene therapy INS1202 in people with the disease.

Virtual Field is now known as Carrot as part of a rebrand aimed at broadening the company’s focus beyond virtual ...

The Robert J. Dole VA Medical Center has an ace in the hole when it comes to figuring out which medications work best for each veteran it serves.

A laboratory test — or assay — developed in Sudbury, Ont., to measure the effectiveness of chemotherapy is one step closer to ...

Allogene Therapeutics (NASDAQ:ALLO) used its fourth-quarter 2025 conference call to outline what management described as a ...

Testing identified significant impurity formation when tirzepatide is compounded with B12 variants, suggesting chemical incompatibility that is not evaluated under FDA review pathways. Uncertainty ...

Investment lead by OTB Ventures and Alpha Intelligence Capital Waiv develops AI-powered precision testing to better identify and stratify patients in the clinic and in clinical trials, transforming ...

CDNA launches VANTx, an AI-driven cloud platform that turns complex transplant datasets into insights to support clinical research and real-world evidence.

This aromatherapy-infused body lotion isn’t just a beauty product; it’s a key part of my bedtime routine. Here’s why it helps me sleep better.

Waiv Raises $33M to expand AI precision oncology tests, strengthen pharma partnerships, and broaden global lab access globally.

In an interview with CURE, Dr. Susana Campos, clinical director of the Division of Gynecologic Oncology and assistant professor of medicine at Harvard Medical School, discussed re ...

A study questioned the use of brain volume loss as a clinical trial endpoint in PPMS after finding a weak link to disability progression.